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Corticosteroids (C) rapidly suppress Cluster Headache
(CH) attacks during the time required for the preventative
agent verapamil (V), to have effects [1]. However, both
drugs are often unsatisfactory. We present the case of a
woman, affected by Chronic Cluster Headache (CCH),
successfully treated with high doses of C and V. Moreover,
we treated similarly 20 Episodic Cluster Headache (ECH)
patients with satisfactory results. A 62-years old housewife,
in 2006 had an isolated cluster (ICHD-II) of 40 days dura-
tion, unresponsive to NSAIDs. In 2008, she had a second
cluster, responsive to 6 mg sc sumatriptan; oxygen inhala-
tion was ineffective. Patient was successfully treated with
V 240 mg and prednisone (P) 50 mg/day per os for 7 days,
tapered in a month.In January 2009, she had a new cluster,
that became chronic with 2-8 attacks/24 hours, not
responsive to P 50 mg/day, V 320 mg/day, lithium
(750 mg/day), valproate (1000 mg/day). When we saw her,
in August 2011, she had 5 attacks/24 h, despite taking V
per os 320 mg/day. Patient was administered methylpred-
nisolone (MP) 500 mg iv/day for 2 days, then 250 mg for
3 days, followed by P 25 mg per os for 2 days, tapered in
8 days. V was increased gradually to 600 mg/day. In the
following month there were no attacks. In September, she
presented 1-3 attacks/24h nocturnal and mild, lasting
15 min. V was increased to 680 mg/day with disappear-
ance of attacks. In November, V was slowly reduced to
320 with no recurrence. To the best of our knowledge this
is the first report about high doses of iv MP associated
with high doses of V per os being effective in CCH. Data
are being elaborated on a group of 20 ECH patients
treated similarly with good results. If confirmed, our
findings warrant the reevaluation of the doses and timing
of these drugs in CH with appropriate clinical trials.
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